Similarly, while EBI2 up-regulation in ME/CFS patients could possibly contribute to some immune dysfunction observed in these patients, its contributions to other symptoms such as POTS, brain fog and fatigue, need to be determined. Here, GPR183 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.